Bax
Showing 1 - 25 of 565
Hemophilia B Trial in Pune (RIXUBIS: On-Demand, RIXUBIS: Prophylaxis)
Completed
- Hemophilia B
- RIXUBIS: On-Demand
- RIXUBIS: Prophylaxis
-
Pune, Maharashtra, IndiaSahyadri Super Speciality Hospital
Aug 4, 2022
Carpal Tunnel Syndrome Trial in Toulouse (BAX, Tourniquet, Lidocaine)
Not yet recruiting
- Carpal Tunnel Syndrome
- BAX
- +4 more
-
Toulouse, Haute-Garonne, FranceClinique Médipôle Garonne
Sep 14, 2023
Congenital Heart Disease in Children Trial in Japan (BAX602, No Intervention)
Recruiting
- Congenital Heart Disease in Children
- BAX602
- No Intervention
-
Obu City, Aichi Prefecture, Japan
- +3 more
Jan 25, 2023
Immunoglobulin A Nephropathy Trial (SM101, Placebo)
Withdrawn
- Immunoglobulin A Nephropathy
- SM101
- Placebo
- (no location specified)
Feb 3, 2022
TAK-660 in Surgical Procedures for People With Hemophilia A.
Active, not recruiting
- Hemophilia A
- PEGylated Recombinant Factor VIII
-
Tokyo, JapanTakeda Selected Site
Dec 13, 2022
Hemophilia A Trial in Worldwide (BAX 888)
Active, not recruiting
- Hemophilia A
- BAX 888
-
Phoenix, Arizona
- +15 more
Nov 23, 2021
Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (BAX930, Standard of care)
Recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- BAX930
- Standard of care
-
Atlanta, Georgia
- +29 more
May 4, 2022
Healthy Volunteers Trial in Vienna (Fucoidan (extract of Laminaria japonica), Placebo)
Completed
- Healthy Volunteers
- Fucoidan (extract of Laminaria japonica)
- Placebo
-
Vienna, AustriaUniversity Clinic for Clinical Pharmacology, General Hospital Vi
May 3, 2021
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- TAK-755
- (no location specified)
Feb 9, 2023
Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802))
Terminated
- Hemophilia A
- Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)
-
Peoria, Illinois
- +23 more
Oct 5, 2021
Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor
Completed
- Hemophilia A
- Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
- PEGylated Recombinant Factor VIII
-
Sofia, Bulgaria
- +7 more
Apr 30, 2021
Metastatic Colorectal Cancer Trial in United States (BAX69 + infusional 5-FU/LV, BAX69 + panitumumab, BAX69 + 5-FU/LV)
Terminated
- Metastatic Colorectal Cancer
- BAX69 + infusional 5-FU/LV
- +3 more
-
Port Saint Lucie, Florida
- +11 more
May 3, 2021
Hemophilia A Trial in Worldwide (PEGylated Recombinant Factor VIII)
Completed
- Hemophilia A
- PEGylated Recombinant Factor VIII
-
Phoenix, Arizona
- +82 more
May 3, 2021
(Usage Results Study) of RIXUBIS in Adult and Pediatric
Completed
- Hemophilia B
- RIXUBIS
-
Daegu, Korea, Republic of
- +4 more
Apr 30, 2021
Hemophilia A Trial in Worldwide (PEGylated Recombinant factor VIII (rFVIII))
Completed
- Hemophilia A
- PEGylated Recombinant factor VIII (rFVIII)
-
Gainesville, Florida
- +21 more
Apr 30, 2021
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites Trial in United States (BAX69 Single-Route Arm, BAX69
Terminated
- Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
- BAX69 Single-Route Arm
- BAX69 Double-Route Arm
-
Miami, Florida
- +5 more
Dec 22, 2020
Congenital Thrombotic Thrombocytopenic Purpura Trial in Worldwide (TAK-755)
Recruiting
- Congenital Thrombotic Thrombocytopenic Purpura
- TAK-755
-
Atlanta, Georgia
- +20 more
Mar 29, 2022
Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor
Completed
- Hemophilia A
- Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
- PEGylated Recombinant Factor VIII
-
Phoenix, Arizona
- +38 more
Apr 30, 2021
Hereditary Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (Recombinant ADAMTS13)
Completed
- Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
- Recombinant ADAMTS13
-
Dublin, Ohio
- +10 more
May 3, 2021
Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor
Completed
- Hemophilia A
- Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
- PEGylated Recombinant Factor VIII
-
Aurora, Colorado
- +71 more
Apr 30, 2021
Hemophilia B Trial in Worldwide (BAX 326 (Recombinant factor IX))
Completed
- Hemophilia B
- BAX 326 (Recombinant factor IX)
-
Rosario, Argentina
- +41 more
Apr 30, 2021